Health

Results: 4345-4356 of 4398

OKYO Pharma Announces Public Offering of Ordinary Shares

PR Newswire associated0

Therabody Doubles Down in Beauty Launching TheraFace Mask

*The Microban® technology used in this product is similar to acids found in nature and is used in multiple consumer product applications.

Microban launches Ascera(TM): a patent-pending, cutting-edge antimicrobial technology inspired by nature

PR Newswire associated0

Veeva Introduces Study Portal and VeevaID to Streamline Research Site Trial Execution

PR Newswire associated0

New Batch Release Application for Life Sciences Manufacturing to Speed Time-to-Market and Reduce Cost

Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine

Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023

PR Newswire associated0

Scivita Medical Single-use Broncho Videoscope Solution Showcased at ERS 2023

PR Newswire associated0

Microbiome Insights, Inc. Releases Updated Guide for Researchers Planning and Conducting Microbiome Studies

PR Newswire associated0

J INTS BIO, WCLC 2023 - Presentation of Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI

PR Newswire associated0

Medac GmbH Advances Pharmacovigilance Technology for Safety Monitoring of its Drugs with ArisGlobal Solutions

Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a Class I innovative drug from BioRay Pharmaceutical, has been approved for marketing in China